Registered Nurse Practitioner
Resume:
CURRICULUM VITAE
Page *
NAME: Jonathan P. Cottingham
EDUCATION: Master of Science in Nursing-Family Nurse Practitioner 2013
University of Memphis
Memphis, Tennessee
Bachelor of Science in Nursing 2010
Arkansas State University
Graduate 2001
Valley View High School
PROFESSIONAL
EXPERIENCE:
Comprehensive Pain Specialists / Therapix Oct 2015-August-2019
Advanced Practitioner Registered Nurse FNP-BC
Performed all initial patient evaluations.
Formulated and managed care plans and medication management.
Ordered appropriate lab work and imaging.
Ordered appropriate intervention for pain relief.
Managed walk in urgent care for our patients.
The Children’s Clinic P.A. / JPC Dec 2013-Oct 2015 / June 2017- November 2018
Advanced Registered Nurse Practice
Evaluated and treated pediatric patients from newborn to 18 years.
Treated multiple levels of care for pediatrics
Managed care plans and medication.
Crittenden Regional Hospital 2010-2014
ER, RN
Treated minor and critical patients as a bedside nurse.
Administered medication and acute health care (trauma)
Coordinated stroke and STEMI protocols.
NEA Baptist 2005-2010 ER/ RN
Treated minor and critical patients as a bedside nurse.
Administered medication and acute health care (trauma
PROFESSIONAL Emergency Nurse Association
SOCIETIES: American Nurses Association
Page 2
LICENSES/
CERTIFICATIONS: Arkansas State Board of Nursing Licenses- RN, APRN
American Academy of Nursing Practitioners – APRN-BC
Basic Life Support Certification, ACLS
RESEARCH
EXPERIENCE: “A Phase III Double Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of XXX Administered Concomitantly with XXX.”
“A Phase IIIb, open, randomized, controlled, multicenter study to assess the co-administration of XXX with XXX at 2 and 4 months of age, the co-administration of XXX with XXX at 2, 4, and 6 months of age and the co-administration of XXX with XXX at 12 to 15 months of age.”
“Immunogenicity and safety study of XXX vaccine at an end of shelf-life potency compared to XXX vaccine when both given on a 2-dose schedule to healthy children in their second year of life.”
“A Phase 2b, randomized, controlled, observer-blind, multi-center study assessing the effectiveness, immunogenicity and safety of XXX vaccine administered to healthy adolescents in the U.S.”
“The effects on growth and tolerance of a routine infant formula fed to term infants.”
“Growth of healthy term infants fed formula containing XXX from XXX.”
“The effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants.”
“A Phase 2b, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Effectiveness, Immunogenicity and Safety of Novartis XXX to Healthy Adolescents in the U.S.”
Contact this candidate